Role of endogenous adenosine in postdefibrillation bradyarrhythmia and hemodynamic depression.
- 1 July 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 80 (1) , 128-137
- https://doi.org/10.1161/01.cir.80.1.128
Abstract
In halothane-nitrous oxide-anesthetized pigs, the effect of the competitive adenosine antagonist, BW-A1433U (a derivative of 1,3-dipropyl-8-phenylxanthine), on postdefibrillation bradyarrhythmia and hemodynamic depression was investigated. In protocol 1, repetitive episodes of ventricular fibrillation lasting 15 seconds before transthoracic DC shock were performed in five animals, before (control) and after the administration of BW-A1433U (5 mg/kg i.v.). An unsuccessful initial shock was immediately followed by a rescue shock of 40 A. In ventricular fibrillation episodes requiring rescue shocks, nine of 19 episodes (47%) exhibited second- or third-degree atrioventricular block at 15 seconds postdefibrillation compared with only one of 16 BW-A1433U episodes (6%). In protocol 2, the effect of BW-A1433U was determined in the presence of dipyridamole, a nucleoside uptake blocker known to potentiate the cardiac actions of adenosine. To counter the hypotensive effect of dipyridamole, methoxamine was continuously infused at 0.015 mg/kg/min i.v. Sequential episodes of ventricular fibrillation lasting 45 seconds were terminated by shocks of 40 A in the presence of methoxamine alone, after dipyridamole (1.5-7.5 mg i.v.), and after BW-A1433U (5 mg/kg i.v.). Over the first 15 seconds postdefibrillation, BW-A1433U significantly (p less than 0.05) increased the number of spontaneous beats (31 +/- 2) and systolic/diastolic blood pressure (111 +/- 4/67 +/- 5 mm Hg; mean +/- SEM; n = 9) compared with both methoxamine (16 +/- 2 beats; 98 +/- 14/52 +/- 12 mm Hg; n = 5) and dipyridamole (8 +/- 3 beats; 58 +/- 11/27 +/- 6 mm Hg; n = 9), respectively. Rapid infusion of BW-A1433U during dipyridamole postdefibrillation periods raised heart rate and blood pressure to preventricular fibrillation levels within 30 seconds. Thus, BW-A1433U can reverse and prevent postdefibrillation bradyarrhythmia and hemodynamic depression. Endogenous adenosine may be an important mediator of postdefibrillation cardiovascular collapse.This publication has 31 references indexed in Scilit:
- Exercise capacity after acute aminophylline administration in angina pectorisThe American Journal of Cardiology, 1989
- Adenosine in hemorrhagic shock: Possible role in attenuating sympathetic activationLife Sciences, 1987
- Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation.Journal of Clinical Investigation, 1987
- Methoxamine versus epinephrine on regional cerebral blood flow during cardiopulmonary resuscitationCritical Care Medicine, 1987
- Transient increase in release of adenosine during rapid cardiac pacing; transient effects on overdrive suppression of ventricular automaticityCardiovascular Research, 1987
- Internal Countershock Produces Myocardial Damage and Lactate Production Without Myocardial Ischemia in Anesthetized DogsAnesthesiology, 1987
- The plasma catecholamine response to ventricular tachycardia induction and external countershock during electrophysiologic testingJournal of the American College of Cardiology, 1986
- Ventricular Defibrillation — A Comparative Trial Using 175-J and 320-J ShocksNew England Journal of Medicine, 1982
- Factors controlling impulse transmission with special reference to A-V conductionAmerican Heart Journal, 1975